Evaluasi Kejadian Ikutan Pasca Imunisasi pada Peserta Vaksinasi di Puskesmas Teluk Dalam, Tenggarong Seberang
Evaluation of Adverse Events Following Immunization in Vaccination Participants at Teluk Dalam Tenggarong Seberang Community Health Center
DOI:
https://doi.org/10.25026/mpc.v15i1.636References
[2] https://covid19.go.id/artikel/2022/05/21/situasi-covid-19-di-indonesia-update-21-mei-2022 (Diakses Pada 23 Mei 2022)
[3] https://covid19.go.id/index.php/artikel/2021/12/28/10-vaksin-covid-19-yang-sudah-dapatkan-izin-penggunaan-darurat-dari-badan-pom (Diakses Pada 23 Mei 2022)
[4] A. Riad, A. Pokorná, 2021. Prevalence of covid-19 vaccine side effects among healthcare workers in the Czech Republic,” J. Clin. Med., vol. 10, no. 7, pp. 1–18, doi: 10.3390/jcm10071428.
[5] R. Desnita, V. S. Sapardi, 2022. Kejadian Ikutan Pasca Imunisasi ( KIPI ) Vaksin Covid-19 Dosis Pertama dan Kedua Adverse Events After Immunization ( AEFI ) First and Second Dose of Covid-19 Vaccine, vol. 6, no. 1, pp. 20–26.
[6] Supangat, E. N. Sakinah, 2021. COVID-19 Vaccines Programs: adverse events following immunization (AEFI) among medical Clerkship Student in Jember, Indonesia,” BMC Pharmacol. Toxicol., vol. 22, no. 1, pp. 1–7, doi: 10.1186/s40360-021-00528-4.
[7] R. Urakawa, E. T. Isomura, 2022. Impact of age, sex and medical history on adverse reactions to the first and second dose of BNT162b2 mRNA COVID-19 vaccine in Japan: a cross-sectional study, BMC Infect. Dis., vol. 22, no. 1, pp. 1–8, doi: 10.1186/s12879-022-07175-y.
[8] A. Pormohammad et al., 2021. Efficacy and safety of covid-19 vaccines: A systematic review and meta-analysis of randomized clinical trials, Vaccines, vol. 9, no. 5, pp. 1–21, 2021, doi: 10.3390/vaccines9050467.
[9] J. Sprent, C. King, 2021. COVID-19 vaccine side effects: The positives about feeling bad, Sci. Immunol., vol. 6, no. 60, pp. 2–4, 2021, doi: 10.1126/sciimmunol.abj9256.
[10] Meo SA, Bukhari IA, 2021. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines, Eur. Rev. Med. Pharmacol. Sci., vol. 25, no. 3, pp. 1663–1669.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Proceeding of Mulawarman Pharmaceuticals Conferences

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.